News|Articles|May 9, 2025
FDA Action Update, April 2025: Approvals, Expansion, and Authorization
Author(s)Isabella Ciccone, MPH
Catch up on any of the neurology news headlines you may have missed over the course of April 2025, compiled all into one place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in April 2025, making a number of decisions on potential new therapeutic agents including granting approvals, an clearance, an expanded indication, and an authorization.
Advertisement
Advertisement